Kymera Therapeutics, Inc. - Common Stock (KYMR)
CUSIP: 501575104
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 80,235,145
- Total 13F shares
- 22,191,421
- Share change
- +2,594,652
- Total reported value
- $862,345,865
- Price per share
- $38.86
- Number of holders
- 94
- Value change
- +$92,686,286
- Number of buys
- 53
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 501575104?
CUSIP 501575104 identifies KYMR - Kymera Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501575104:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
3.4%
|
2,720,489
|
$168,670,000 | — | 31 Dec 2020 | |
| BVF INC/IL |
13F
|
Company |
3.3%
|
2,630,658
|
$163,101,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
3%
|
2,442,060
|
$151,408,000 | — | 31 Dec 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.4%
|
1,959,211
|
$121,471,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.1%
|
1,690,579
|
$104,050,000 | — | 31 Dec 2020 | |
| Deer IX & Co. Ltd. |
13F
|
Company |
2.2%
|
1,755,356
|
$97,949,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.8%
|
1,416,631
|
$87,832,000 | — | 31 Dec 2020 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.89%
|
713,865
|
$44,260,000 | — | 31 Dec 2020 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
0.88%
|
704,059
|
$43,652,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.78%
|
623,060
|
$38,631,000 | — | 31 Dec 2020 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.6%
|
479,605
|
$29,735,000 | — | 31 Dec 2020 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
0.58%
|
463,298
|
$28,724,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.49%
|
392,076
|
$24,309,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.31%
|
250,000
|
$15,500,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
191,921
|
$11,899,000 | — | 31 Dec 2020 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.21%
|
169,771
|
$10,526,000 | — | 31 Dec 2020 | |
| Woodline Partners LP |
13F
|
Company |
0.21%
|
169,687
|
$10,521,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
160,545
|
$9,954,000 | — | 31 Dec 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.19%
|
151,575
|
$9,398,000 | — | 31 Dec 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.18%
|
147,700
|
$9,157,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
121,926
|
$7,559,000 | — | 31 Dec 2020 | |
| Logos Global Management LP |
13F
|
Company |
0.14%
|
110,920
|
$6,877,000 | — | 31 Dec 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.12%
|
100,000
|
$6,200,000 | — | 31 Dec 2020 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.12%
|
100,000
|
$6,200,000 | — | 31 Dec 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.09%
|
69,355
|
$4,300,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
61,334
|
$3,803,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
40,260
|
$2,496,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
38,833
|
$2,408,000 | — | 31 Dec 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.04%
|
31,592
|
$1,959,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
27,930
|
$1,732,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.03%
|
25,200
|
$1,562,000 | — | 31 Dec 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
23,001
|
$1,426,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
22,086
|
$1,369,000 | — | 31 Dec 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.02%
|
20,000
|
$1,240,000 | — | 31 Dec 2020 | |
| Athanor Capital, LP |
13F
|
Company |
0.02%
|
19,492
|
$1,209,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
19,437
|
$1,205,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
17,483
|
$1,084,000 | — | 31 Dec 2020 | |
| HighVista Strategies LLC |
13F
|
Company |
0.02%
|
17,117
|
$1,061,000 | — | 31 Dec 2020 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.02%
|
16,053
|
$995,000 | — | 31 Dec 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
15,250
|
$946,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
0.02%
|
15,000
|
$930,000 | — | 31 Dec 2020 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.02%
|
13,116
|
$813,000 | — | 31 Dec 2020 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.02%
|
13,000
|
$806,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
10,917
|
$677,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
10,787
|
$669,000 | — | 31 Dec 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
10,491
|
$650,000 | — | 31 Dec 2020 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.01%
|
9,014
|
$559,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
7,900
|
$490,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
7,410
|
$460,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
6,800
|
$422,000 | — | 31 Dec 2020 |
Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q1 2021
As of 31 Mar 2021,
Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,191,421 shares.
The largest 10 holders included
BVF INC/IL, Redmile Group, LLC, FMR LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Deer IX & Co. Ltd., BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
94
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
74
Q1 2021 holders
94
Holder diff
20
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.